Project Management Institute

Speed Trials

Big Pharma Teams Are Using New Tech Tools to Expedite Clinical Tests and Boost ROI

The pharmaceutical industry has a profit problem. Large companies in the sector have seen the ROI on R&D projects drop by 69 percent since 2010, with the price to bring new drugs to market surging from US$1.5 billion in 2016 to nearly US$2 billion in 2017, according to Deloitte. But trimming R&D isn't an option -- without new products, pharma companies wither and die.
registered user content locked

Log in or join PMI to gain access

or Register



Related Content